betamethasone-17,21-dipropionate has been researched along with Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bissonnette, R; Dickstein, D; Estrada, YD; Guttman-Yassky, E; Labuda, T; Malik, K; Oliva, M; Peng, X; Suarez-Farinas, M; Suprun, M; Todd, D; Ungar, B; Xu, H | 1 |
1 trial(s) available for betamethasone-17,21-dipropionate and Hyperplasia
| Article | Year |
|---|---|
Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Biomarkers; Cell Differentiation; Clobetasol; Cytokines; Dermatitis, Atopic; Female; Humans; Hyperplasia; Male; Middle Aged; Placebo Effect; Psoriasis; Skin; Tacrolimus; Young Adult | 2017 |